StockData
Renalytix plc logo

Renalytix plc (RNLXY) stock

RNLXYOTCServices-Medical LaboratoriesFiscal year ends June 30Also trades as RENXF
Financials through Q1 FY2025, quarter ended Sep 30, 2024Last filing: 10-Q on Nov 19, 2024
$3.56+0.06 (+1.57%)

Close on Oct 19, 2026Market cap $375.75MP/E –Yield –

Renalytix operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Renalytix's operating cash flow for the twelve months ending Sep 30, 2024 was -$24.44M. For fiscal 2024 it was -$30.11M. The highest annual figure on record is -$6.16M in fiscal 2019.

Annual operating cash flow

PeriodPeriod endValueChange
FY2024Jun 30, 2024-$30.11M–
FY2023Jun 30, 2023-$34.09M–
FY2022Jun 30, 2022-$45.92M–
FY2021Jun 30, 2021-$28.40M–
FY2020Jun 30, 2020-$9.52M–
FY2019Jun 30, 2019-$6.16M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q1 FY2025CQ3 2024Sep 30, 2024-$3.84M–
Q4 FY2024CQ2 2024Jun 30, 2024-$7.83M–
Q3 FY2024CQ1 2024Mar 31, 2024-$4.86M–
Q2 FY2024CQ4 2023Dec 31, 2023-$7.92M–
Q1 FY2024CQ3 2023Sep 30, 2023-$9.50M–
Q4 FY2023CQ2 2023Jun 30, 2023-$8.63M–
Q3 FY2023CQ1 2023Mar 31, 2023-$10.10M–
Q2 FY2023CQ4 2022Dec 31, 2022-$8.23M–
Q1 FY2023CQ3 2022Sep 30, 2022-$7.12M–
Q4 FY2022CQ2 2022Jun 30, 2022-$14.17M–
Q3 FY2022CQ1 2022Mar 31, 2022-$7.02M–
Q2 FY2022CQ4 2021Dec 31, 2021-$14.24M–
Q1 FY2022CQ3 2021Sep 30, 2021-$10.49M–
Q4 FY2021CQ2 2021Jun 30, 2021-$5.10M–
Q3 FY2021CQ1 2021Mar 31, 2021-$4.73M–

More Renalytix figures

See a number that looks wrong?